Literature DB >> 20690047

Applications of tissue microarray technology.

Ronald Simon1.   

Abstract

Tissue microarrays (TMAs) have become a standard tool for tissue-based research during the last decade. In cancer research, depending on the available data attached to the arrayed tissue, three main types of arrays are commonly manufactured. Prevalence TMAs have no further data available and are suited to estimate the frequency of the occurrence of a particular alteration. Progression arrays include tissues of different stages of disease, and are instrumental to study the role of a marker protein for tumor initiation, progression, or metastatic growth. Prognosis TMAs contain tissues with patient follow-up data. These TMAs are the key to uncover the clinical impact of molecular markers. In combination with normal tissue arrays representing healthy tissues, prevalence, progression, and prognosis TMAs allow for a rapid and comprehensive analysis of molecular markers in human cancers. TMAs are also successfully used for many noncancer applications, such as Alzheimer's or inflammatory disease research.

Entities:  

Mesh:

Year:  2010        PMID: 20690047     DOI: 10.1007/978-1-60761-806-5_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  MALDI tissue imaging: from biomarker discovery to clinical applications.

Authors:  Lisa H Cazares; Dean A Troyer; Binghe Wang; Richard R Drake; O John Semmes
Journal:  Anal Bioanal Chem       Date:  2011-05-04       Impact factor: 4.142

2.  Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer.

Authors:  Yi Tan; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2012-12-06

3.  Tissue microarray analysis of cyclin-dependent kinase inhibitors p21 and p16 in Fuchs dystrophy.

Authors:  Mario Matthaei; Eva-Maria Lackner; Huan Meng; Jessica L Hicks; Alan K Meeker; Charles G Eberhart; Albert S Jun
Journal:  Cornea       Date:  2013-04       Impact factor: 2.651

Review 4.  [Application of bio-chip in lung cancer research].

Authors:  Min Zhu; Jun Yu; Wenli Zhou; Xiangning Fu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-05

5.  Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.

Authors:  Linlin Zhang; Shang Guo; Joseph H Schwab; G Petur Nielsen; Edwin Choy; Shunan Ye; Zhan Zhang; Henry Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

6.  Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms.

Authors:  Niclas C Blessin; Patrick Spriestersbach; Wenchao Li; Tim Mandelkow; David Dum; Ronald Simon; Claudia Hube-Magg; Florian Lutz; Florian Viehweger; Maximillian Lennartz; Christoph Fraune; Vera Nickelsen; Wilfried Fehrle; Cosima Göbel; Sören Weidemann; Till Clauditz; Patrick Lebok; Katharina Möller; Stefan Steurer; Jacob R Izbicki; Guido Sauter; Sarah Minner; Frank Jacobsen; Andreas M Luebke; Franziska Büscheck; Doris Höflmayer; Waldemar Wilczak; Eike Burandt; Andrea Hinsch
Journal:  Cell Oncol (Dordr)       Date:  2020-03-05       Impact factor: 6.730

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.